Emedonline: Telemedicine Medication Management System

描述（由研究者提供）：据估计，美国医疗保健系统每年花费约766亿美元。大约10%的住院与药物问题有关，每年造成的损失高达500亿美元。了解不遵守的原因并确定帮助患者遵循其方案的方法可以改善健康结果并降低相关费用。我们建议确定药物管理系统是否能提高老年高血压患者的依从性。这个名为Emedonline的药物管理系统使用标准的移动电话技术，按照设定的时间间隔给病人打电话，给出服用处方药物的语音、文字和图形指示，并分发药物。它特别侧重于修改社会互动因素，并提供一种工具来加强管理过程。我们确定了实现第一阶段和第二阶段目标的三个关键目标：开发Emedonline以促进医疗保健提供者的药物处方方案，并促进患者的药物依从性。2. 评估医疗保健提供者、药剂师和患者对该服务的接受程度。3. 评估对药物依从性、感知到的社会支持和对健康命运的控制感的影响。在第一阶段，我们将通过由医疗保健提供者、药剂师和患者组成的焦点小组来检查需求；开发Emedonline系统的原型；对样品进行概念测试；并制订第二期发展的详细规格。

DESCRIPTION (provided by investigator): Medication non-compliance is estimated to cost the US healthcare system an estimated $76.6 billion a year. Approximately 10% of hospital admissions are related to medication issues, costing up to $50 billion annually. Understanding the causes of noncompliance and identifying methods to help patients follow their regimens may improve health outcomes and reduce related costs. We propose to determine whether a medication management system improves compliance among elderly patients being treated for hypertension. The medication management system, called Emedonline, uses standard cellular phone technology to call patients at programmed intervals, gives voice, text, and graphic instructions for taking prescribed medications, and dispenses the medications. It focuses specifically on modifying social interaction factors and providing a tool to enhance the administration process. We have identified three key objectives toward achieving Phase I and Phase II goals: 1. Develop Emedonline to facilitate prescribing medication regimens for healthcare providers, and facilitate medication compliance for patients. 2. Assess the acceptability of the service among healthcare providers, pharmacists, and patients. 3. Evaluate effects on medication compliance, perceived social support, and feelings of control over health destiny. During Phase I, we will examine requirements through focus groups with a sample of healthcare providers, pharmacists, and patients; develop a prototype of the Emedonline system; conduct a concept test with the sample; and create detailed specifications for Phase II development.